Matthew H. Hunt
FDA investigator
Appears on 2 documents from 2012, mostly at sites in Missouri. Most often cites written procedures; deviations (21 CFR 211.100(b)).
- 2
- Documents on file
- 4.0
- Observations per 483
- 2012
- First seen
- 2012
- Most recent
What they cite most
From 4 observations- 21 CFR 211.100(b)Written procedures; deviations1
- 21 CFR 211.113(b)Control of microbiological contamination1
- 21 CFR 211.160(a)General requirements1
- 21 CFR 211.80(a)General requirements1
Activity by year
2012: 2
Where
Missouri 2
Often inspects with
Is Matthew H. Hunt coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2012-02-13 | EIR Meridian Medical Technologies a Pfizer CompanyFeb 13, 2012 · Brentwood, Missouri | Brentwood, Missouri | — | |
| 2012-02-13 | 483 Meridian Medical Technologies a Pfizer CompanyFeb 13, 2012 · Brentwood, Missouri | Brentwood, Missouri | 4 |
About this profile
What does Matthew H. Hunt inspect?
Matthew H. Hunt appears on 2 documents on file covering 1 site, mostly in Missouri.
What do they cite most often?
21 CFR 211.100(b) (written procedures; deviations), followed by 21 CFR 211.113(b) and 21 CFR 211.160(a).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Matthew H. Hunt is dated Feb 13, 2012.